Subject |
Oneness Biotech Co., Ltd. received an India patent on FB704A, an anti-IL6 fully-human antibody new drug. |
- Date of occurrence of the event: 2022/03/11
- Company name: ONENESS BIOTECH CO., LTD.
- Relationship to the Company (please enter “head office” or “subsidiaries”): head office
- Reciprocal shareholding ratios: NA
- Cause of occurrence:
The Company has been informed by the patent agency that the FB704A, an anti-IL6 fully-human antibody new drug, has been granted an India patent titled “ANTIBODIES TO INTERLEUKIN-6 AND USES THEREOF” under the patent number 389592.
- Countermeasures: None
- Any other matters that need to be specified: None
|